Novartis secures FDA approval for Egaten as fascioliasis treatment
Novartis has achieved a significant milestone with the FDA's approval of Egaten (triclabendazole) for the treatment of fascioliasis in patients aged six years and older. ... Read More
WHO announces first malaria vaccine trials in Ghana, Kenya, and Malawi
The World Health Organization (WHO) has announced a pivotal step in global health: the initiation of the world's first malaria vaccine trials in Ghana, Kenya, ... Read More